These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26689989)

  • 1. MICAL2 is a novel human cancer gene controlling mesenchymal to epithelial transition involved in cancer growth and invasion.
    Mariotti S; Barravecchia I; Vindigni C; Pucci A; Balsamo M; Libro R; Senchenko V; Dmitriev A; Jacchetti E; Cecchini M; Roviello F; Lai M; Broccoli V; Andreazzoli M; Mazzanti CM; Angeloni D
    Oncotarget; 2016 Jan; 7(2):1808-25. PubMed ID: 26689989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MICAL2 is a novel nucleocytoplasmic shuttling protein promoting cancer invasion and growth of lung adenocarcinoma.
    Zhou W; Liu Y; Gao Y; Cheng Y; Chang R; Li X; Zhou Y; Wang S; Liang L; Duan C; Zhang C
    Cancer Lett; 2020 Jul; 483():75-86. PubMed ID: 32360180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MICAL2 contributes to gastric cancer cell migration via Cdc42-dependent activation of E-cadherin/β-catenin signaling pathway.
    Wang Q; Qi C; Min P; Wang Y; Ye F; Xia T; Zhang Y; Du J
    Cell Commun Signal; 2022 Sep; 20(1):136. PubMed ID: 36064550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MICAL2 is expressed in cancer associated neo-angiogenic capillary endothelia and it is required for endothelial cell viability, motility and VEGF response.
    Barravecchia I; Mariotti S; Pucci A; Scebba F; De Cesari C; Bicciato S; Tagliafico E; Tenedini E; Vindigni C; Cecchini M; Berti G; Vitiello M; Poliseno L; Mazzanti CM; Angeloni D
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2111-2124. PubMed ID: 31004710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Lipoxygenase promotes epithelial-mesenchymal transition through the ERK signaling pathway in gastric cancer.
    Lin H; Weng J; Mei H; Zhuang M; Xiao X; Du F; Lin L; Wu J; Chen Z; Huang Y; Chen F; Wang X
    J Gastroenterol Hepatol; 2021 Feb; 36(2):455-466. PubMed ID: 32667711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition.
    Zhu LY; Zhang WM; Yang XM; Cui L; Li J; Zhang YL; Wang YH; Ao JP; Ma MZ; Lu H; Ren Y; Xu SH; Yang GD; Song WW; Wang JH; Zhang XD; Zhang R; Zhang ZG
    Cancer Lett; 2015 Jul; 363(1):71-82. PubMed ID: 25864591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MICAL2 Mediates p53 Ubiquitin Degradation through Oxidating p53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance.
    Lu J; Li Y; Wu Y; Zhou S; Duan C; Dong Z; Kang T; Tang F
    Theranostics; 2018; 8(19):5289-5306. PubMed ID: 30555547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel oncogenic seRNA promotes nasopharyngeal carcinoma metastasis.
    Tan Y; Jiang C; Jia Q; Wang J; Huang G; Tang F
    Cell Death Dis; 2022 Apr; 13(4):401. PubMed ID: 35461306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MICAL2 Contributes to Gastric Cancer Cell Proliferation by Promoting YAP Dephosphorylation and Nuclear Translocation.
    Qi C; Min P; Wang Q; Wang Y; Song Y; Zhang Y; Bibi M; Du J
    Oxid Med Cell Longev; 2021; 2021():9955717. PubMed ID: 34650666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A research of STEAP1 regulated gastric cancer cell proliferation, migration and invasion in vitro and in vivos.
    Zhang Z; Hou WB; Zhang C; Tan YE; Zhang DD; An W; Pan SW; Wu WD; Chen QC; Xu HM
    J Cell Mol Med; 2020 Dec; 24(24):14217-14230. PubMed ID: 33128353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTMR2 promotes invasion and metastasis of gastric cancer via inactivating IFNγ/STAT1 signaling.
    Jiang L; Liu JY; Shi Y; Tang B; He T; Liu JJ; Fan JY; Wu B; Xu XH; Zhao YL; Qian F; Cui YH; Yu PW
    J Exp Clin Cancer Res; 2019 May; 38(1):206. PubMed ID: 31113461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha B-crystallin promotes the invasion and metastasis of gastric cancer via NF-κB-induced epithelial-mesenchymal transition.
    Chen D; Cao G; Qiao C; Liu G; Zhou H; Liu Q
    J Cell Mol Med; 2018 Jun; 22(6):3215-3222. PubMed ID: 29566309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H; Zhao Y; Cao L; Zhang J; Wang Y; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3447-3454. PubMed ID: 30246429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
    Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cullin3 promotes breast cancer cells metastasis and epithelial-mesenchymal transition by targeting BRMS1 for degradation.
    Huo X; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
    Oncotarget; 2015 Dec; 6(39):41959-75. PubMed ID: 26544623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer.
    Li Z; Liu Z; Dong S; Zhang J; Tan J; Wang Y; Ge C; Li R; Xue Y; Li M; Wang W; Xiang X; Yang J; Ding H; Geng T; Yao K; Song X
    Am J Pathol; 2015 Sep; 185(9):2412-20. PubMed ID: 26362716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.
    Zhao J; Yang C; Guo S; Wu Y
    Int J Clin Exp Pathol; 2015; 8(9):10784-91. PubMed ID: 26617790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High intratumoral expression of eIF4A1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.
    Gao C; Guo X; Xue A; Ruan Y; Wang H; Gao X
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):310-319. PubMed ID: 32147684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.